CRBP EPS Estimates
Corbus Pharmaceuticals Holdings, Inc.
$4.52
+$0.19(+4.39%)
39
Overall
60
Value
36
Tech
23
Quality
Market Cap
$87.42M
Volume
1.07M
52W Range
$4.22 - $20.56
Target Price
$35.89
CRBP EPS estimates: the consensus estimate for Corbus Pharmaceuticals Holdings, Inc.'s current fiscal year is -$5.62 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CRBP EPS Estimates
- EPS estimate, current quarter
- $-1.45
- EPS estimate, next quarter
- $-1.46
- EPS estimate, current year
- $-5.62
- EPS estimate, next year
- $-6.47
- EPS growth, 3-year
- +16.54%
| Fiscal year | EPS |
|---|---|
| 2025 | $-5.90 |
| 2024 | $-3.68 |
| 2023 | $-10.31 |
| 2022 | $-10.15 |
| 2021 | $-11.10 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRBP | $4.52 | +4.4% | 1.07M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corbus Pharmaceuticals Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW